Fairmount Funds Management

Investor type Hedge Fund

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 5
Average round size
info
The average size of a deal this fund participated in
$131M
Portfolio companies 5
Lead investments 1
Exits 4
Key employees Soon

Areas of investment

  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Health Care
  • Biopharma

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Fairmount Funds Management:
Typical Co-investors
Fairmount Funds Management is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Fairmount Funds Management:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
AE Jarrah Capital Group -
Commenda Capital Atlanta, Georgia, United States
Grindrod Durban, KwaZulu-Natal, South Africa
Grupo Prisma Chile, Santiago Metropolitan Region, Vitacura
Macif Innovation -
Race Capital California, Hayward, United States
Sibessor 2 -
STV Group Douglassville, Pennsylvania, United States
Yingke Beite Investment Management Enterprise China, Guangdong, Shenzhen
Yorkshire Cancer Research Harrogate, North Yorkshire, United Kingdom

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Trevi Therapeutics

Biotechnology
Health Care
Pharmaceutical
$55M07 Apr 2022 Connecticut, United States

Point Biopharma

Biopharma
Biotechnology
Therapeutics
$165M01 Jul 2021 Indianapolis, Indiana, United States

Nuvalent

Biotechnology
Life Science
Therapeutics
$135M11 May 2021 Cambridge, Massachusetts, United States

Verona Pharma

Biotechnology
Pharmaceutical
Therapeutics
$200M17 Jul 2020 London, England, United Kingdom

UNUM Therapeutics

Biotechnology
Health Care
Therapeutics
$104M06 Jul 2020 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Fairmount Funds Management?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: